Maintenance / Service

WHITE PAPERS AND CASE STUDIES

• HRSD Gains New Operational Awareness To Improve Wastewater Operations

  In southeastern Virginia, Hampton Roads Sanitation District (HRSD) handles wastewater treatment for 1.7 million people in 20 cities and counties. Sea-level rise, unusually high tides, and extreme storms prompted a $1.2 billion program—the Sustainable Water Initiative for Tomorrow (SWIFT) that involves replenishing the Potomac aquifer with up to 100 million gallons of SWIFT Water (water treated to meet drinking water standards and matched to the existing groundwater chemistry in the aquifer) per day, an action that may slow or reduce the impact of sea level rise by slowing land settling, or subsidence.

• Technology And Clinical Monitoring

  Clinical trials are evolving due to multiple forces that are affecting what was once a very standard approach. This notion of change has been constantly streaming into monitoring processes and the clinical monitoring role.

• Beyond The Paper Binder: Comprehensive Cancer Centers Of Nevada Adopts Remote Monitoring

  Explore how Comprehensive Cancer Centers of Nevada (CCCN) modernized its regulatory documentation practices to enable remote site monitoring and improve efficiencies.

• 5G NR Design For eMBB

  Enhanced mobile broadband (eMBB) will extend the current mobile experience with high data throughput by more than 10 Gbps, high system capacity by more than 1,000x that of LTE, and a much better spectral efficiency than LTE. This white paper shows how Cadence software overcomes eMBB design challenges.

• Method Optimization: Assay Development Following Compendial Methods

  There was a short time frame of only 7 weeks to complete assay optimization and conduct pre-validation studies within the confines of USP<621>.

• Pacira Optimizes Manufacturing Process For Maximum Production Throughput

  Being unable to garner insights from the data for impactful decisions drove this emerging specialty pharmaceutical company to seek a solution that could accelerate data aggregation, modeling and prediction.

• Regulatory Approval For Novel Device Achieved With Comprehensive Clinical Data Management

  Find out how data capture and management activities, programming, and medical writing for a clinical study report were supported to solve the major diagnostic challenge of distinguishing between bacterial and viral infections.

• Democratizes Batch Data Management For AAV Gene Therapies And Accelerates CMO Collaboration

  Read the story of a leading clinical-stage biotechnology company developing gene therapy product candidates in the retinal, metabolic, and neurodegenerative therapeutic areas.

• Lower Valley Water District's Journey To Becoming Geospatially Driven

  By making the strategic decision to incorporate geographic information system (GIS) technology into multiple facets of this water utility’s business, they addressed challenges and improved workflow efficiencies to propel the organization ahead.

• Atlantic Research Group Builds Competitive Advantage With Medrio EDC

  By using Medrio’s EDC platform, learn how Atlantic Research Group was able to achieve the flexibility needed to span multiple therapeutic areas and eliminate redundancy in documentation.

• Developing A Novel Approach To Real-Time Monitoring Of Antibody Titer

  As the industry continues to apply innovative manufacturing tools and solutions, it also needs real-time monitoring to keep up with a modern production suite. 

• Accelerating Results For Healthcare Brands Through Advocacy, Materials Science Expertise And Integrated Packaging Capabilities

  Any change to packaging design for an approved pharmaceutical product is a time consuming, detail-orientated effort, even with small brand-driven changes––so when governments update packaging regulations on a larger scale, a company’s entire product line could be impacted, creating change management projects for sometimes hundreds of items. When Health Canada introduced amendments to the existing Food and Drug Regulations for non-prescription, over-the-counter (OTC) drug products in 2014, pharmaceutical organizations selling products in the Canadian marketplace knew they had a significant challenge to overcome